Amant Frédéric AMC - Foto Gillissen - IMG_6116

Professor Frédéric Amant

Frédéric Amant (MD, PhD) (°1967) received his medical degree from the University of Leuven (KU Leuven), Belgium, in 1992 and completed his specialty training in Obstetrics and Gynecology in Leuven, Pretoria (South Africa) and Concepción (Chile) in 1998. He completed his subspecialty training in Gynecologic Oncology in Pretoria and Leuven in 2000. He pioneered the sentinel lymph node biopsy in breast cancer and the nerve sparing radical hysterectomy at UZ Leuven. He is professor at the KU Leuven, and at the University of Amsterdam, the Netherlands, visiting professor at the University of Bergen, Norway, and honorary professor at the University of Pretoria, South Africa. He is specialist at the Netherlands Cancer Institute in Amsterdam.

Frédéric Amant heads the Gynecologic Oncology research section at the University of Leuven and at the Netherlands Cancer Institute. In 2005, he founded the ESGO taskforce on Cancer in Pregnancy, now the “International Network on Cancer, Infertility and Pregnancy” (INCIP) (, and chairs this network up until now. Since 2014, INCIP also registers young women who aim to preserve their fertility. At the KU Leuven, he founded the fund for Innovative Cancer Research, a platform that funds oncologic projects for teams at this institution. In addition, Frédéric Amant founded TRACE, the tumor xenograft platform at the KU Leuven, which bridges basic research closer and the clinic. He co-founded ENITEC, the European Network on Individualized Treatment of Endometrial Cancer. He has authored 484 PubMed publications, in journals such as NEJM, Nature, the Lancet journals, JAMA Oncology and the Journal of Clinical Oncology, which add to his H-index of 63.

Scroll to Top